Related Experiment Video

Updated: Mar 14, 2026

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice
07:25

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice

Published on: September 25, 2019

7.5K

Corrigendum to "Chronic hepatitis B: immune pathogenesis and emerging immunotherapeutics" [Curr. Opin. Pharmacol. 30

Kyong-Mi Chang1, Mengfei Liu2

  • 1University of Pennsylvania Perelman School of Medicine, USA; Philadelphia Corporal Michael J. Crescenz VA Medical Center, USA.

Current Opinion in Pharmacology
|October 7, 2016
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix
10:37

Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix

Published on: October 20, 2021

3.5K
A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
11:34

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target

Published on: May 10, 2022

2.7K

Related Experiment Videos

Last Updated: Mar 14, 2026

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice
07:25

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice

Published on: September 25, 2019

7.5K
Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix
10:37

Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix

Published on: October 20, 2021

3.5K
A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
11:34

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target

Published on: May 10, 2022

2.7K

Related Concept Videos

Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

456
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
456

Articles linked to this work by shared authors, journal, and citation graph.

Gene-Based Rare Variant Burden Analyses Across Biobanks Identify Novel High-Risk Genes for Thoracic Aortic Disease.

medRxiv : the preprint server for health sciences·2026

Epigenome-Wide Association Study of Abdominal Aortic Aneurysm Identifies Central Role for Inflammatory Pathways.

Circulation·2026

A peach esterase/lipase mediates lipid remodeling as a protective mechanism against chilling injury.

Plant physiology·2026

Cross-Ancestry and Phenome-Wide Associations of Cancer-Specific Polygenic Risk Scores.

JCO precision oncology·2026

PLL-g-HPA Hydrogel Microneedles Loaded With Rhoifolin Target Macrophages to Alleviate Fibroblast Senescence for Diabetic Wound Healing.

Advanced healthcare materials·2026

Multi-ancestry sequencing analysis in 293,141 participants identifies predisposition DNA repair genes associated with HCC risk.

JHEP reports : innovation in hepatology·2026

Polycystic ovary syndrome: An insight into pathophysiology, current management, and emerging therapeutic approaches.

Current opinion in pharmacology·2026

Re-evaluating the neuroprotective landscape of Nigella sativa: Molecular mechanisms, nanomedicine, and clinical translation.

Current opinion in pharmacology·2026

Therapeutic targeting of trained immunity in cancer.

Current opinion in pharmacology·2026

Cyclosporine A revisited: Molecular mechanisms, non-immune physiological pathways, and the architecture of multi-organ toxicities.

Current opinion in pharmacology·2026

Pharmacological control of inflammation via innate immune memory manipulation.

Current opinion in pharmacology·2026

miR-124 upregulation as a new therapeutic strategy: The evolving role of obefazimod in ulcerative colitis.

Current opinion in pharmacology·2026

Epitope-diverse autoantibodies induce neutrophil-epithelial niches driving kidney injury in ANCA-associated glomerulonephritis.

The Journal of experimental medicine·2026

Interpreting peripheral immune phenotypes in Parkinson's disease: an immune-context framework for biomarker qualification.

Reviews in the neurosciences·2026

Therapeutic Drug Monitoring of Golimumab to Predict Disease Activity and Antidrug Antibodies Status in Patients with Ankylosing Spondylitis.

Therapeutic drug monitoring·2026

Appropriateness of antiphospholipid antibody testing and its impact on diagnostic yield and clinical outcomes: a multicentre cohort study.

Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis·2026

Tissue-specific inflammatory responses to systemic LPS in mice with LysM-lineage Hmgb1 deletion.

Brain, behavior, & immunity - health·2026

Beyond the Classic Triad: A Case of GQ1b Antibody-Positive Bickerstaff Brainstem Encephalitis Overlap Syndrome.

Cureus·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us